Applied Nutrition Income Statement

Financials in millions GBP. Fiscal year is August - July.

Millions GBP. Fiscal year is Aug - Jul.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '25 Jan 31, 2025	Jul '24 Jul 31, 2024	Jul '23 Jul 31, 2023	Jul '22 Jul 31, 2022	Jul '21 Jul 31, 2021	Jul '20 Jul 31, 2020
Revenue	88.35	86.15	60.78	35.23	21.81	11.2
Revenue Growth (YoY)	150.80%	41.74%	72.54%	61.51%	94.76%	-
Cost of Revenue	47.46	44.86	33.81	18.65	10.28	5.29
Gross Profit	40.89	41.29	26.97	16.58	11.53	5.91
Selling, General & Admin	21.62	17.52	9.3	6.8	4.5	1.43
Other Operating Expenses	-	-	-	-	-0.03	-0.18
Operating Expenses	21.62	17.52	9.3	6.8	4.47	1.25
Operating Income	19.27	23.77	17.67	9.78	7.07	4.67
Interest Expense	-	-	-	-0.02	-0.03	-
Interest & Investment Income	0.93	0.73	0.07	-	-	-
Pretax Income	20.2	24.5	17.74	9.76	7.04	4.67
Income Tax Expense	4.86	5.76	4.11	1.67	1.2	0.76
Net Income	15.34	18.74	13.63	8.08	5.84	3.91
Net Income to Common	15.34	18.74	13.63	8.08	5.84	3.91
Net Income Growth	89.77%	37.46%	68.65%	38.38%	49.60%	-
Shares Outstanding (Basic)	5	5	5	-	-	-
Shares Outstanding (Diluted)	5	5	5	-	-	-
EPS (Basic)	3.07	3.75	2.73	-	-	-
EPS (Diluted)	3.07	3.75	2.73	-	-	-
EPS Growth	-	37.46%	-	-	-	-
Free Cash Flow	5.32	5.32	7.35	6.04	2.25	2.33
Free Cash Flow Per Share	1.06	1.06	1.47	-	-	-
Gross Margin	46.28%	47.93%	44.37%	47.06%	52.88%	52.81%
Operating Margin	21.81%	27.59%	29.08%	27.76%	32.41%	41.66%
Profit Margin	17.36%	21.75%	22.43%	22.95%	26.78%	34.87%
Free Cash Flow Margin	6.03%	6.18%	12.08%	17.14%	10.31%	20.83%
EBITDA	19.96	24.36	18.08	10.04	7.3	4.71
EBITDA Margin	22.59%	28.27%	29.75%	28.49%	33.46%	42.06%
D&A For EBITDA	0.69	0.59	0.41	0.26	0.23	0.04
EBIT	19.27	23.77	17.67	9.78	7.07	4.67
EBIT Margin	21.81%	27.59%	29.08%	27.76%	32.41%	41.66%
Effective Tax Rate	24.07%	23.52%	23.15%	17.16%	17.03%	16.30%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.